InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ellis Sean, Director. Director active across 1 company, notably Entera Bio Ltd.. In total, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €49k. History available since 18 January 2022. The latest transaction was disclosed on 18 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
10,000 shares@ US$2.8050.040% mcap100.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000163
Canonical exit: 18 Apr 2022 (T+90)
10,000 shares@ US$2.8050.040% mcap50.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000163:0
Canonical exit: 18 Apr 2022 (T+90)
2 of 2 declarations
About Ellis Sean
Ellis Sean is a Director at Entera Bio Ltd. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He collaborates with other members to ensure the company's compliance and performance.
